Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary

被引：19

作者：

Papp, Kim A. ^{[1
,2
]}

Haraoui, Boulos ^{[11
]}

Kumar, Deepali ^{[3
,4
]}

Marshall, John K. ^{[6
,7
]}

Bissonnette, Robert ^{[12
]}

Bitton, Alain ^{[13
]}

Bressler, Brian ^{[15
]}

Gooderham, Melinda ^{[8
,18
]}

Ho, Vincent ^{[15
]}

Jamal, Shahin ^{[16
]}

Pope, Janet E. ^{[9
,10
]}

Steinhart, A. Hillary ^{[4
,5
]}

Vinh, Donald C. ^{[13
,14
]}

Wade, John ^{[15
,17
]}

机构：

[1] K Papp Clin Res, 135 & 139 Union St East, Waterloo, ON N2J 1C4, Canada

[2] Prob Med Res, 135 & 139 Union St East, Waterloo, ON N2J 1C4, Canada

[3] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada

[4] Univ Toronto, Fac Med, Toronto, ON, Canada

[5] Mt Sinai Hosp, Toronto, ON, Canada

[6] McMaster Univ, Dept Med, Hamilton, ON, Canada

[7] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada

[8] Queens Univ, Fac Med, Kingston, ON, Canada

[9] Univ Western Ontario, Fac Med, London, ON, Canada

[10] St Josephs Hlth Care, London, ON, Canada

[11] Ctr Hosp Univ Montreal, Montreal, PQ, Canada

[12] Innovaderm Res Inc, Montreal, PQ, Canada

[13] McGill Univ, Hlth Ctr, Montreal, PQ, Canada

[14] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada

[15] Univ British Columbia, Fac Med, Vancouver, BC, Canada

[16] Vancouver Coastal Hlth, Vancouver, BC, Canada

[17] Vancouver Gen Hosp, Vancouver, BC, Canada

[18] Queens Univ, Prob Med Res, Kingston, ON, Canada

来源：

JOURNAL OF RHEUMATOLOGY | 2019年 / 46卷 / 07期

关键词：

VACCINATION; IMMUNOSUPPRESSION; IMMUNE-MEDIATED DISEASE; RHEUMATOID-ARTHRITIS; INFLUENZA; AUTOIMMUNE; DISEASES; REASONS;

D O I：

10.3899/jrheum.180784

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The use of immunosuppressive therapies for immune-mediated disease is associated with an elevated risk of infections and related comorbidities. While many infectious diseases can generally be prevented by vaccines, immunization rates in this specific patient population remain suboptimal, due in part to uncertainty about their efficacy or safety under these clinical situations. To address this concern, a multidisciplinary group of Canadian physicians with expertise in dermatology, gastroenterology, infectious diseases, and rheumatology developed evidence-based clinical guidelines on vaccinations featuring 13 statements that are aimed at reducing the risk of preventable infections in individuals exposed to immunosuppressive and immunomodulatory agents.

引用

页码：751 / 754

页数：4

共 50 条

[41] Systematic review of safety and efficacy of belimumab in treating immune-mediated disorders
Kaegi, Celine
Steiner, Urs C.
Wuest, Benjamin
Crowley, Catherine
Boyman, Onur
ALLERGY, 2021, 76 (09) : 2673 - 2683
[42] Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders
Whitehouse, Christiane E.
Fisk, John D.
Bernstein, Charles N.
Berrigan, Lindsay I.
Bolton, James M.
Graff, Lesley A.
Hitchon, Carol A.
Marriott, James J.
Peschken, Christine A.
Sareen, Jitender
Walker, John R.
Stewart, Sherry H.
Marrie, Ruth Ann
Katz, Alan
Lix, Lisa M.
Patten, Scott B.
Singer, Alexander
El-Gabalawy, Renee
Zarychanski, Ryan
NEUROLOGY, 2019, 92 (05) : E406 - E417
[43] Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
Kaegi, Celine
Wuest, Benjamin
Schreiner, Jens
Steiner, Urs C.
Vultaggio, Alessandra
Matucci, Andrea
Crowley, Catherine
Boyman, Onur
FRONTIERS IN IMMUNOLOGY, 2019, 10
[44] Uptake and safety of pneumococcal vaccination in adults with immune-mediated inflammatory diseases: a UK wide observational study
Nakafero, Georgina
Grainge, Matthew J.
Card, Tim
Mallen, Christian D.
Van-Tam, Jonathan S. Nguyen
Abhishek, Abhishek
RHEUMATOLOGY, 2024,
[45] Negative effect of immunosuppressive therapy in the performance of the QuantiFERON Gold In-Tube test in patients with immune-mediated inflammatory diseases
Ramos, Jose M.
Masia, Mar
Rodriguez, Juan C.
Lopez, Cristina
Padilla, Sergio
Robledano, Catalina
Navarro-Blasco, Francisco J.
Matarredona, Jaime
Garcia-Sepulcre, Mariana F.
Gutierrez, Felix
CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 13 (03) : 177 - 186
[46] Quality of Life in Patients with Immune-Mediated Inflammatory Diseases
Russell, Anthony S.
Gulliver, Wayne P.
Irvine, E. Jan
Albani, Salvatore
Dutz, Jan P.
JOURNAL OF RHEUMATOLOGY, 2011, 38 : 7 - 19
[47] Perceived quality of life by patients with immune-mediated inflammatory diseases treated with biological therapies. SACVINFA study
Chamorro-de-Vega, Esther
Calvo, Alberto
Fernandez-Pacheco, Maria
Hernandez-Muniesa, Belen
Romero-Jimenez, Rosa
Casado-Gomez, Araceli
Ramirez, Esther
FARMACIA HOSPITALARIA, 2024, 48 (06) : T265 - T271
[48] Treatment Strategies for Patients With Immune-Mediated Inflammatory Diseases
Curtis, Jeffrey R.
Ogdie, Alexis
George, Michael D.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (17): : 1726 - 1728
[49] Effects of implementing a vaccination tool in the electronic medical record on vaccination coverage of patients with immune-mediated inflammatory diseases: a prospective cohort study
Fierens, Liselotte
Coenen, Sofie
Joly, Johan
Vanhoutvin, Tine
De Dycker, Els
Bertrand, Delphine
Van Laer, Eva
Penny, Jens
Reumers, Jan
Verschueren, Patrick
De Haes, Petra
De Munter, Paul
Ferrante, Marc
INFECTIOUS DISEASES, 2024, 56 (10) : 870 - 879
[50] Antecedent immunosuppressive therapy for immune-mediated inflammatory diseases in the setting of a COVID-19 outbreak
Veenstra, Jesse
Buechler, Connor R.
Robinson, Gabrielle
Chapman, Stephanie
Adelman, Madeline
Tisack, Aaron
Dimitrion, Peter
Todter, Erika
Kohen, Laurie
Lim, Henry W.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : 1696 - 1703

← 1 2 3 4 5 →